Inventor
BELANGER DAVID B
US15 patents
⚠️ This page may combine multiple inventors who share the name “BELANGER DAVID B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALCON UNIVERSAL LTD
5 patentsUS6348496B1Feb 19, 2002
15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
ALCON UNIVERSAL LTD8 citations72
US6462061B1Oct 8, 2002
Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for treatment of dry eye
ALCON UNIVERSAL LTD3 citations61
US6326499B1Dec 4, 2001
Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye
ALCON UNIVERSAL LTD5 citations61
US6320062B1Nov 20, 2001
15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
ALCON UNIVERSAL LTD5 citations61
US6255343B1Jul 3, 2001
2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use
ALCON UNIVERSAL LTD5 citations61
SCHERING CORP
4 patentsUS7563798B2Jul 21, 2009
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
SCHERING CORP11 citations83
US7576085B2Aug 18, 2009
Imidazopyrazines as cyclin dependent kinase inhibitors
SCHERING CORP10 citations82
US7511040B2Mar 31, 2009
Imidazopyrazines as protein kinase inhibitors
SCHERING CORP8 citations82
US7652020B2Jan 26, 2010
Compounds for the treatment of inflammatory disorders
SCHERING CORP5 citations62
ALCON INC
2 patentsADAMS CHRISTOPHER M
2 patentsUS9765067B2Sep 19, 2017
Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
ADAMS CHRISTOPHER M0 citations38
US9957254B2May 1, 2018
Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
ADAMS CHRISTOPHER M0 citations36